Randomized phase II trial comparing IG-001 versus paclitaxel against first-line advanced ovarian cancer.
Vuong N. Trieu
Employment or Leadership Position - Sorrento Therapeutics
Stock Ownership - Sorrento Therapeutics
Research Funding - Sorrento Therapeutics
Monica Choi
Employment or Leadership Position - Sorrento Therapeutics
Stock Ownership - Sorrento Therapeutics
Research Funding - Sorrento Therapeutics
Larn Hwang
Employment or Leadership Position - Sorrento Therapeutics
Stock Ownership - Sorrento Therapeutics
Research Funding - Sorrento Therapeutics
Osmond D'Cruz
Employment or Leadership Position - Sorrento Therapeutics
Stock Ownership - Sorrento Therapeutics
Research Funding - Sorrento Therapeutics